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Actively steering the chondrogenic differentiation of mesenchymal
stromal cells (MSCs) into either permanent cartilage or hypertrophic
cartilage destined to be replaced by bone has not yet been possible.
During limb development, the developing long bone is exposed to
a concentration gradient of oxygen, with lower oxygen tension in
the regiondestined tobecomearticular cartilageandhigheroxygen
tension in transient hypertrophic cartilage. Here, we prove that
metabolic programming of MSCs by oxygen tension directs chon-
drogenesis into either permanent or transient hyaline cartilage.
Human MSCs chondrogenically differentiated in vitro under hyp-
oxia (2.5% O2) produced more hyaline cartilage, which expressed
typical articular cartilage biomarkers, including established inhibi-
tors of hypertrophic differentiation. In contrast, normoxia (21%O2)
prevented the expression of these inhibitors and was associated
with increased hypertrophic differentiation. Interestingly, gene
network analysis revealed that oxygen tension resulted in meta-
bolic programming of the MSCs directing chondrogenesis into
articular- or epiphyseal cartilage-like tissue. This differentiation pro-
gramresembled theembryological developmentof thesedistinct types
of hyaline cartilage. Remarkably, the distinct cartilage phenotypes
were preserved upon implantation in mice. Hypoxia-preconditioned
implants remained cartilaginous, whereas normoxia-preconditioned
implants readily underwent calcification, vascular invasion, and subse-
quent endochondral ossification. In conclusion, metabolic program-
ming of MSCs by oxygen tension provides a simple yet effective
mechanism by which to direct the chondrogenic differentiation pro-
gram into either permanent articular-like cartilage or hypertrophic
cartilage that is destined to become endochondral bone.
tissue engineering | chondral defects | skeletogenesis | cell therapy |
regenerative medicine
The limited regenerative capacity of articular cartilage, com-bined with its susceptibility to damage from high-energy im-
pacts, repetitive shear, and torsional forces, has led to a growing
need for new therapeutic strategies. The use of multipotent cells,
such as mesenchymal stromal cells (MSCs), to form de novo
hyaline cartilage remains a promising strategy (1). Importantly,
unlike articular chondrocytes, MSCs can be isolated in high
numbers from various sources (2, 3) without the creation of a
secondary defect in the diseased joint (2, 4).
During the past decades, substantial progress has been made
in gaining control over the derivation of chondrocytes from pro-
genitor cells (5). Unfortunately, it is not yet possible to steer the
differentiation of MSCs into the formation of permanent hyaline
cartilage. Instead, the present protocols for chondrogenically dif-
ferentiating MSCs result in the production of neocartilage that is
characterized by hypertrophic differentiation (6–9). Consequently,
the newly formed cartilage undergoes endochondral ossification
upon implantation (8, 10–12). In fact, it has been reported that,
currently, the most efficient way to engineer new bone from mul-
tipotent progenitor cells is via implantation of in vitro-generated
neocartilage (6). Accumulating evidence indeed suggests that the
current chondrogenic differentiation protocols for MSCs result in
hypertrophic hyaline cartilage that more closely resembles growth
plate-like cartilage than articular cartilage (7, 13). In line with
these observations, the current protocols do not induce the tran-
scription of genes encoding regulators of articular cartilage ho-
meostasis that effectively inhibit hypertrophic differentiation (7, 13).
During embryonic development, the permanent articular car-
tilage and the transient hypertrophic cartilage both arise from
the same cartilaginous anlage. However, specific sets of stimuli
drive these two hyaline cartilages into distinct differentiation
programs. Attempts to identify the required stimuli to drive the
formation of permanent articular cartilage have been largely un-
successful to date. Recent studies suggested that oxygen levels
might play a role in driving hypertrophic differentiation (14, 15).
Interestingly, in the cartilage anlage, permanent articular cartilage
is formed under hypoxic conditions, whereas hypertrophic dif-
ferentiation of cartilage and subsequent endochondral ossifica-
tion are associated with vascular invasion and, consequently,
much higher levels of oxygen. Remarkably, standard differentia-
tion protocols for MSCs occur in normoxic conditions. Based on
these observations, we hypothesized that the proper choice of
oxygen tensionmight be a powerfulmechanismwith which to steer
chondrogenic differentiation of MSCs.
Here, we report that oxygen levels control the chondrogenic
differentiation program of MSCs to become either articular- or
epiphyseal-like cartilage through metabolic programming.
Results
Hypoxia Stimulates Chondrogenic Differentiation of MSCs. Micro-
masses of MSCs were differentiated into the chondrogenic lin-
eage for up to 35 d in the presence of TGF-β3 in either normoxic
or hypoxic conditions. Histological analysis demonstrated little
to no positive glycosaminoglycan staining after 7 d of culture in
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either normoxic or hypoxic conditions (Fig. 1A). In contrast, at
21 d of chondrogenic differentiation, intense glycosaminoglycan
staining throughout the pellet was observed in pellets cultured in
hypoxia compared with modest glycosaminoglycan staining in
pellets cultured in normoxia. Particularly in the periphery of the
hypoxic cultured pellets, chondron formation was visible at lower
density. After 35 d, glycosaminoglycan staining intensified in the
pellets cultured in hypoxia. Interestingly, in micromasses cul-
tured in normoxia glycosaminoglycan, staining remained lower
and positive staining for glycosaminoglycans was predominantly
found in the center of the pellet. Strikingly, these MSC-derived
chondrocytes were characterized by a hypertrophic phenotype
due to their enlarged size and the presence of lacunae (Fig. 1B).
This phenomenon was absent under hypoxic conditions. More-
over, the rim of pellets cultured in normoxia suggested the
presence of a more stratified cartilaginous matrix, indicating fi-
brous tissue formation. Biochemical quantification corroborated
enhanced glycosaminoglycan deposition in hypoxia compared
with normoxia at 21 and 35 d of differentiation (Fig. 1C).
Effect of Oxygen on Gene Expression Profile of Chondrogenically
Differentiating MSCs. Whole-genome gene expression analysis
was performed on MSCs that were chondrogenically differenti-
ated for 7, 21, or 35 d under either hypoxic or normoxic culture
conditions. These gene expression profiles were compared with
the gene expression profiles of the initially undifferentiatedMSCs.
In total, 503 genes were significantly differentially expressed with
a more than twofold change in at least one of the time points
compared with the undifferentiated MSCs over the 35-d culture
period. Hierarchical clustering of these 503 significantly differen-
tially expressed genes revealed that during the first 21 d of culture,
the time in culture accounted for larger changes in gene expression
than those changes caused by differential oxygen exposure. How-
ever, after 35 d of chondrogenic differentiation, the effect of oxy-
gen tension becamemore dominant. Cells cultured in normoxia for
35 d demonstrated more resemblance to cells cultured for 21 d in
normoxia than to those cells cultured for 35 d in hypoxia. This
observation suggested a potential difference in cell fate (Fig. S1A).
Comparison of undifferentiated MSCs with chondrogenically dif-
ferentiated pellets at day 35 revealed that more genes were up-
regulated during normoxic culture compared with hypoxic culture
(160 vs. 131 genes, respectively). In hypoxia, more genes were
down-regulated compared with normoxic culture (93 vs. 127 genes,
respectively) (Fig. 2A). Comparing overall differences in gene ex-
pression between hypoxia and normoxia demonstrated that 60
genes were up-regulated and nine genes were down-regulated
more than twofold at day 35 (Fig. S1B).
Differentially expressed genes between hypoxia and normoxia
at day 35 were used to analyze gene/protein network interactions.
Using Markov clustering algorithms, two key nodes within the
network were observed (Fig. 2B). Metabolism-related genes, pre-
dominantly involving regulation of glycolysis, characterized the
smaller cluster. The larger node consisted predominantly of genes
important for the formation and function of articular cartilage
matrix, such as TGF-β1, collagen type II (COL2A1), and sex-
determining region Y-box 9 (SOX9). Moreover, it included several
genes that encoded proteins associated with inhibition of hyper-
trophic differentiation, such as FGF receptor 3 (FGFR3) and
parathyroid hormone 1 receptor (PTH1R). The expression of these
anabolic genes is up-regulated in hypoxia. In contrast, functional
biomarkers of hypertrophic differentiation, such as collagen type
X (COL10A1), matrix metalloproteinase 13 (MMP13), and ca-
thepsin K (CTSK), were up-regulated in normoxia.
Pathway analysis revealed that the differences between hyp-
oxia and normoxia at day 7 were dominated by biofunctions that
are related to metabolism, proliferation, and cell death. More-
over, an important, significant, and progressive change in the
classifiers’ cellular function and maintenance and tissue de-
velopment was observed over time. In particular, this process was
initiated at day 7 with a difference in “embryonic development,”
followed by a transient increase in “connective tissue development
and function” at day 21 and, finally, an increase of “skeletal and
muscular system development and function” at day 35 (Fig. 2C).
Taken together, these data suggested that continuous hypoxia
steered the chondrogenic fate of MSCs in a manner that re-
sembled natural embryological development.
Hypoxia Induces an Articular Cartilage-Like Profile in Chondrogenically
Differentiated MSCs. We validated that hypoxia enhanced the
transcription of typical hyaline cartilage markers, such as SOX9,
COL2A1, and aggrecan (ACAN) using quantitative PCR (qPCR)
analysis (Fig. 3). Previously, we identified a panel of markers able to
discriminate the two subtypes of hyaline cartilage: the permanent
articular cartilage and the hypertrophic growth plate cartilage (7).
The articular cartilage-enriched gene transcripts of gremlin 1
(GREM1), frizzled-related protein (FRZB), and Dickkopf WNT
signaling pathway inhibitor 1 (DKK1), which are established in-
hibitors of hypertrophic differentiation (7, 16), were robustly in-
creased under hypoxic conditions, whereas under normoxic
conditions, these genes did not increase markedly (Fig. 3). The
hypertrophic cartilage-enriched gene transcripts of COL10A1,
MMP13, and pannexin 3 (PANX3) mRNA levels were strongly up-
regulated under normoxic conditions compared with hypoxic
conditions. The increased expression of the secreted antagonists
GREM1, FRZB, and DKK1 at the mRNA level in hypoxia was
corroborated by protein expression analysis. The protein levels of
these three secreted proteins in culture medium were significantly
higher after 35 d of chondrogenic differentiation under hypoxia
compared with normoxia (Fig. 4). Together, these findings sug-
gested that oxygen tension is selectively able to induce MSCs to
express biomarkers that correlate with either permanent articular
cartilage or transient hypertrophic cartilage.
Continued Hypoxia Is Needed to Retain Chondrogenic Stimulus. We
next explored whether transient exposure to hypoxia was suffi-
cient to steer the chondrogenesis of MSCs toward a permanent
articular cartilage-like phenotype. MSCs were differentiated for
5 wk in normoxia, 5 wk in hypoxia, or 3 wk in hypoxia followed
by 2 wk of normoxia, or 3 wk in normoxia followed by 2 wk in
hypoxia. Hypoxia progressively enhanced glycosaminoglycan de-
position and increased SOX9, ACAN, COL2A1, GREM1, FRZB,
and DKK1 mRNA levels. However, when the hypoxic stress was
alleviated after 3 wk, it reversed the chondrogenic benefit gener-
ated by the initial exposure to hypoxia, as witnessed by decreased
glycosaminoglycan deposition (Fig. 5A). Moreover, when hypoxic
preconditioned micromasses were transferred to normoxia after
Fig. 1. Hypoxia stimulates chondrogenic differ-
entiation of MSCs. (A) Micromasses of MSCs were
cultured for up to 35 d under either normoxic or
hypoxic conditions. Histological analysis of mid-
sagittal sections using Alcian blue and Nuclear Fast
Red was used to visualize chondrogenic differen-
tiation. (B) High-magnification microphotographs
were taken of the center and periphery of the
micromasses to visualize their cartilage pheno-
type. (C) Biochemical analysis of glycosaminoglycans (GAG) was used to quantify chondrogenesis. Data represent the mean of three donors, each
measured in quadruplicate ± SD. *P < 0.05; **P < 0.01. (Scale bars: 100 μm.)
















































21 d, the increased mRNA levels of chondrogenic genes dropped
to levels found in undifferentiated MSCs (Fig. 5B). Inversely,
mRNA expression levels of SOX9, ACAN, COL2A1, GREM1,
FRZB, and DKK1 were not significantly different between MSCs
that were allowed to differentiate chondrogenically for 2 wk in
normoxia followed by 3 wk in hypoxia and MSCs that underwent
5 wk of continuous hypoxic differentiation (Fig. S2). This obser-
vation suggested that alleviation of hypoxia in hyaline cartilage,
particularly after the onset of chondrogenic differentiation be-
tween day 14 and day 21, is detrimental to the expression of genes
that are hallmarks of permanent articular cartilage homeostasis.
Hypoxic Chondrogenic Differentiation of MSCs Strongly Reduces
Calcification upon Implantation. Lastly, we investigated whether
predifferentiation of MSCs in vitro in either hypoxia or normoxia
would affect the fate of the cartilaginous tissue upon s.c. im-
plantation in a nude mouse model. To this end, MSCs were
encapsulated in alginate hydrogels and chondrogenically differ-
entiated for 5 wk in vitro under either hypoxia or normoxia before
implantation. After 5 wk of implantation, hypoxia-preconditioned
samples stained intensely for glycosaminoglycans, whereas nor-
moxia-preconditioned samples only stained weakly (Fig. 6A). It is
noteworthy that normoxic preconditioned samples demonstrated
striking invasion of non–cartilage-forming cells that are presumably
of the host. Furthermore, normoxic preconditioned samples
stained strongly positive for calcium, indicating tissue calcification
(Fig. 6B), and demonstrated the abundant presence of blood
vessels (Fig. 6C). This phenotype is in great contrast to the hypoxic
preconditioned samples that remained devoid of blood vessels and
cartilaginous upon implantation for at least the investigated time
frame, whereas the normoxic preconditioning resulted in re-
placement of the implanted cartilage with bone-like tissue (Fig.
6D). Together, these findings demonstrated that oxygen tension
can steer the chondrogenic program of MSCs in tissue-engineer-
ing constructs toward an articular cartilage-like phenotype or
epiphyseal cartilage-like phenotype that will undergo endochon-
dral ossification upon implantation.
Discussion
Cartilage tissue engineering has the potential to regenerate and
restore the articular surface of diarthrodial joints. Consequently,
it offers potential solutions for clinical issues ranging from trauma
to osteoarthritis. Robust formation of permanent hyaline cartilage
is essential to the successful development of such therapies. Be-
cause isolation of articular chondrocytes relies on inflicting ad-
ditional damage to the injured joint, multipotent cells with
chondrogenic potential have been intensively investigated and
found to be a promising cell source for cartilage tissue engineering
(1, 17). Although it is possible to induce chondrogenesis in mul-
tipotent cells, we currently lack the understanding to steer the
Fig. 2. Whole-genome gene expression analysis of chondrogenically differentiated MSCs in either normoxic or hypoxic conditions. (A) Venn diagrams
depicting the gene transcripts with at least a twofold difference that were significantly differentially expressed between day 35 and day 0 under normoxic or
hypoxic culture conditions. (B) Network analysis of predicted gene or protein interactions of gene transcripts differentially expressed in MSCs after 35 d of
chondrogenic differentiation in either normoxic or hypoxic conditions. The red cluster predominantly contains genes involved in glycolysis, and the green
cluster predominantly contains genes with a cartilage signature. Both red and green clusters are up-regulated under hypoxic conditions. In contrast, the
yellow cluster containing COL10A1 and MMP13 is up-regulated in normoxic conditions. (C) We then visualized the significantly different biofunctions be-
tween normoxic and hypoxic culture conditions at day 7, day 21, and day 35 with their respective P values on the y axis. Each data point is based on the gene
expression analysis of three donors.






































chondrogenic differentiation program accurately. In fact, the
current chondrogenic protocols efficiently create hypertrophic
cartilage, which readily undergoes endochondral ossification
upon implantation (6, 9, 12) resembling epiphyseal growth plate
cartilage. However, reproducibly producing permanent articular
cartilage from stem or progenitor cells has remained an un-
solved challenge.
Understanding the natural environments of developmental
processes can yield crucial information on the mechanisms of
steering cell behavior. During development, skeletal formation
in the cartilage anlage, from condensation to formation of ar-
ticular cartilage and endochondral bone, coincides with a spa-
tiotemporal controlled exposure to oxygen tension. Specifically,
the development of articular cartilage in the cartilage anlage
occurs under continuous hypoxic conditions, whereas terminal
hypertrophic differentiation is associated with a physiological
switch toward normoxia induced by orchestrated ingrowth of
blood vessels. Mimicking this environmental factor in vitro has
demonstrated similar effects. In particular, chondrogenic differ-
entiation under hypoxic conditions results in enhanced cartilage
formation and suppresses hypertrophic differentiation (15). In
contrast, chondrogenic differentiation under normoxic conditions
yields less cartilage, which has a clear hypertrophic signature (11,
18, 19). Here, we demonstrate that oxygen tension can, in fact,
metabolically program the chondrogenic fate of MSCs into dif-
ferent subtypes of hyaline cartilage. More precisely, we revealed
that continuous hypoxia induces chondrogenic MSCs to produce
hyaline cartilage that is resistant to hypertrophic differentiation
and subsequent endochondral ossification upon implantation in
mice. This cartilage expressed typical biomarkers of articular
cartilage and established inhibitors of hypertrophic differentiation,
which have been implemented in the maintenance of articular
cartilage homeostasis (7, 16). In contrast, chondrogenic differenti-
ation of MSCs cultured under the conventionally used normoxic
conditions resulted in hypertrophic hyaline cartilage that resembled
epiphyseal cartilage. Interestingly, gene expression analysis in-
dicated that the metabolic programming of the chondrogenic cell
fate correlated with the natural development of distinct carti-
lage subtypes. This observation potentially implicates, or at least
underlines, the powerful and pivotal role of environmental factors,
such as oxygen tension, as cell fate programming agents.
The metabolic programming of MSCs, chondrogenic MSCs, or
matured chondrocytes via oxygen tension has potentially im-
portant consequences. In vitro experimentation on mammalian
cells is nearly exclusively performed under 21% oxygen con-
ditions. This unphysiological environment influences the cell’s
behavior, function, and fate, and is thus able to confound our
fundamental understanding of naturally occurring differentiation
processes, which may have implications for the development of
novel therapies. For example, high oxygen tension metabolically
programs MSCs and chondrocytes to induce the expression of
genes involved in hypertrophic differentiation and matrix remod-
eling, which are also biomarkers for degenerative joint diseases,
such as osteoarthritis. Thus, the standard use of supraphysiological
oxygen levels during in vitro cultures can obscure our interpretation
of in vitro studies on the behavior of cells from diseased tissue as
well as interfere with the reliability of biomarkers that are used in
drug development. Therefore, studying cells in environments that
are as natural as possible, particularly with respect to oxygen ten-
sion, might prove both essential and inevitable.
Understanding the signaling mechanisms that underlie the
metabolic programming of the chondrogenic cell fate might al-
low for the efficient production of either permanent articular
cartilage or transient hypertrophic cartilage without the need for
an extensive in vitro culture period. A possible candidate is the
hypoxia-inducible factor signaling pathway, which is directly
modulated by oxygen tension. Moreover, this pathway is associ-
ated with both chondrogenesis and the induction of hypertrophic
differentiation in articular cartilage during the pathological de-
velopment of osteoarthritis (20). Alternatively, it has recently
been reported that the activity of the PI3K/AKT/FOXO pathway
is influenced by oxygen tension and is able to enhance chondro-
genesis, inhibit hypertrophic differentiation, and prevent endo-
chondral ossification (21). Also, SMAD signaling induced by
members of the TGF-β/BMP family of growth factors is influ-
enced by oxygen tension (22). However, the determination of cell
fate is typically a multistage decision involving multiple signaling
pathways in a spatiotemporal manner. In addition to single can-
didates, it is likely that multiple signaling pathways are able to act
in concert or even synergistically (21). The involvement of mul-
tiple signaling pathways upon exposure to distinct oxygen tension
is also suggested by observations in our current study. Specifically,
although programming of chondrogenic fates elicited a similar
response among donors, differences in cell survival under low
oxygen tensions were marked by interdonor variation. Moreover,
hypoxic preconditioning resulted in implants that are character-
ized by relatively low cell densities. These implants proved
Fig. 3. Hypoxia stimulated the expression of gene transcripts toward an
articular cartilage-like profile. Chondrogenically differentiating MSCs in ei-
ther normoxic or hypoxic conditions were analyzed for gene expression of
the hyaline cartilage markers SOX9, COL2A1, and ACAN; the hypertrophic
cartilage markers COL10A1, MMP13, and PANX3, and the articular cartilage
markers GREM1, FRZB, and DKK1 by qPCR. Data are illustrated in a linear
heat map in which white represents the lowest gene expression and red
represents the highest gene expression, of which the maximal value is given
in fold change. Data represent the mean of three donors, each measured
in triplicate.
Fig. 4. Normoxia increased secretion of GREM1,
FRZB, and DKK1 in culture medium. The articular
cartilage-enriched markers FRZB, GREM1, and
DKK1 were analyzed using ELISA. Data represent
the mean of three donors, each measured in trip-
licate ± SD. *P < 0.05.
















































sufficient for preservation of the chondrocyte phenotype in
implantation studies for at least 5 wk. The long-term effects of
metabolic preconditioning still remain to be elucidated. Our data
indicate that a continuous hypoxic microenvironment is necessary
to preserve the articular cartilage-like phenotype. In particular,
hypoxia induced the expression of trophic factors involved in the
inhibition of hypertrophic differentiation. This observation under-
lines the importance of the progenitor cell’s trophic role in tissue
regeneration. Trophic factors can mediate tissue regeneration in
both direct and indirect manners (23–25). Progressive insight
indicates that current culture and treatment protocols allow pro-
genitor cells to contribute mainly to regenerative effects via trophic
roles rather than direct tissue formation (26). However, it is likely
that the manner in which progenitor cells contribute to tissue re-
generation is based on their preconditioning, manner of application,
and in vivo microenvironment. Our study suggests the possibility of
metabolic programming to prime the trophic role of the MSCs for
a specific role in tissue repair.
The s.c. implantation of the distinctly preprogrammed chon-
drogenic constructs was characterized by remarkably dissimilar
behaviors. Where the hypoxic pretreated implants resembled
permanent mature articular-like cartilage devoid of signs of hy-
pertrophic differentiation, the normoxic pretreated implants readily
underwent hypertrophic differentiation and endochondral ossifica-
tion. Most notably, the normoxic pretreated implants were strongly
invaded by noncartilaginous tissue, which contained a high density of
perfused small blood vessels. This phenomenon might be explained
by the cartilaginous matrix degradation and expression of, for ex-
ample, angiogenic factors that are associated with hypertrophic dif-
ferentiation. Regardless, implanting pretreated implants exposes the
tissue-engineered constructs to an environment that is dependent on
diffusion of oxygen derived from the host for survival. Oxygen-gen-
erating or -scavenging biomaterialsmight prove to be an efficient way
in which to control the chondrogenic differentiation program of pro-
genitor cells in vivo.
Our observations might aid tissue-engineering approaches in
important ways. For example, by inducing cartilage formation
under hypoxic conditions, MSCs may generate permanent articular
cartilage that could be used for better treatment of articular car-
tilage defects. In contrast, by inducing cartilage formation in nor-
moxia, transient and hypertrophic cartilage is formed, which may
be highly suited to endochondral healing of critical bone defects.
Although our study is limited to the role of oxygen-mediated
programming of MSCs in the chondrogenic lineages, it seems likely
that oxygen-mediated metabolic programming may play a broader
role in governing cellular differentiation processes into other tissue
types. Control over oxygen tension and its manipulation appears to
be a powerful tool with which to program the function and fate of
MSCs, ultimately enabling control over their behavior in a clinical
setting. Biomaterials that are designed either to release oxygen
to stimulate cell survival or to mimic hypoxia to stimulate angio-
genesis may, in fact, act as instructive materials for controlled
differentiation of mesenchymal progenitor cells into cartilage and
bone (27, 28).
Taken together, in the present study, we demonstrated that
control over oxygen tension can actively steer the chondrogenic
differentiation program and the fate of MSCs by metabolic pro-
gramming. Importantly, this approach provides tissue-engineering
strategies with a simple yet effective tool to create permanent
articular cartilage or hypertrophic cartilage that will undergo en-
dochondral ossification upon implantation.
Materials and Methods
Patient Material. The use of patient material was approved by the local ethical
committee of the Medisch Spectrum Twente, and informed written consent
was obtained for all samples. Human MSCs of three donors were isolated
from fresh bone marrow samples, cultured as described previously, and used
individually in all presented experiments (29).
Chondrogenesis of MSCs. Micromasses of MSCs were formed by gravitational
seeding of 2.5 × 105 cells in 96 U-shaped, low-attachment well plates
(Greiner Bio-One). Subsequently, chondrogenic differentiation of MSCs was
chemically induced using chondrogenic medium containing 10 ng/mL TGF-β3.
MSCs were allowed to differentiate up to 35 d under either normoxic
(21% oxygen) or hypoxic (2.5% oxygen) conditions. Medium was refreshed
every 3–4 d. For each individual donor, four pellets were pooled for RNA
isolation and two were fixed in 10% (vol/vol) buffered formalin for histo-
logical analysis on days 7, 21 and 35.
Gene Expression Profiling. MSC micromasses were lysed using TRIzol reagent
(Invitrogen). Total RNAwas isolated and purified using aNucleospin RNA II kit
Fig. 5. MSCs underwent chondrogenic differentiation for 5 wk in normoxia,
5 wk in hypoxia, or 3 wk in hypoxia followed by 2 wk in normoxia. (A)
Histological analysis of glycosaminoglycans using Alcian blue and Nuclear
Fast Red on midsagittal sections of MSC micromasses, which were chon-
drogenically differentiated for 3 or 5 wk. (Scale bar: 100 μm.) (B) Gene ex-
pression analysis of the articular cartilage markers SOX9, ACAN, and COL2A1
and the articular cartilage-enriched markers GREM1, FRZB, and DKK1. Data
represent the mean of three donors, each measured in triplicate ± SD. *P <
0.05 for continuously hypoxic cultures compared with week 0; #P < 0.05 for
5-wk cultures that were noncontinuously hypoxic compared with 5-wk
continuously hypoxic cultures.
Fig. 6. In vivo behavior of MSC-laden alginate implants that were pre-
conditioned in either normoxia (21% oxygen) or hypoxia (2.5% oxygen) for
5 wk before implantation. Samples were explanted after 5 wk. Histological
analysis of paraffin-embedded samples stained with Alcian blue with Nu-
clear Fast Red counterstaining for cartilage formation (A), Alizarin Red S for
tissue calcification (B), Masson’s trichrome for vascular invasion (C), and
methylene blue and basic fuchsin for transformation of cartilage into en-
dochondral bone (D). Arrows indicate invading blood vessels containing
erythrocytes. Arrowheads indicate lining cells. Data are representative for
three samples. (Scale bars: 100 μm.)






































(Bioke). Total RNA yields were measured using a Nanodrop2000 instrument
(Isogen LifeScience). High quality of the RNAwas verified using anAgilent 2100
Bioanalyzer (Agilent). For whole-genome gene expression analysis, amplified
cDNA was synthesized with an Ovation PicoSL WTA System kit (NuGEN), bio-
tinylatedwithanEncoreBiotinILmodule (NuGEN), andhybridizedonto Illumina
HumanHT-12 v4 Expression BeadChips. Genes were selected that had at least
a twofolddifferenceandwere significantly differentially expressedaccording to
a one-way ANOVA with a Benjamini–Hochberg false discovery rate correction
and Tukey’s honestly significant difference post hoc test using a cutoff rate of
P= 0.05. Changes in canonical pathways and biofunctions were visualized using
Ingenuity Pathway Analysis software (Ingenuity Systems), and predicted gene/
gene interaction networks were visualized using the Search Tool for the Re-
trieval of Interacting Genes/Proteins (STRING), version 9.0 (30). For single-gene
expression analysis, cDNAwas synthesized using iScript (BioRad), of which 20 ng
was amplified in a real-time qPCR assay using Sensimix (Bioline) and a MyIQ
detection system (BioRad). Gene expression was normalized using ACTB and
B2M as housekeeping genes, which were unaffected by both chondrogenic
differentiation and variation in oxygen tension. Data were visualized as a heat
map generated using the software program R (R Project).
In Vivo Study.Animal experimentationwas performed in accordancewithDutch
law andwith the explicit approval of the local animal care and use committee of
the University Medical Centre Utrecht (approval no. 104231-6). Implants were
formed by encapsulating 1 million MSCs in 100 μL of 1.5% (wt/vol) sodium al-
ginate (Sigma–Aldrich) using 100 mM CaCl2 (Sigma–Aldrich). Implants were
preconditioned for 5 wk in vitro under either normoxic or hypoxic conditions in
chondrogenic medium. Then, the cartilaginous implants were s.c. implanted in
8-wk-old nude male mice (NMRI-Nude; Harlan Laboratories). After 5 wk, the
samples were explanted and histologically analyzed.
Histological Analysis. Cell culture pellets and in vivo samples were washed
and dehydrated in graded series of ethanol at room temperature. After
overnight incubation in butanol at 4 °C, samples were embedded in paraffin
and cut into 5-μm sections. Sections were deparaffinized in xylene and
rehydrated using graded ethanol steps. Sections were stained for cartilage
formation with 0.5% (wt/vol) Alcian blue (Sigma) and 0.1% (wt/vol) Nuclear
Fast Red (Sigma), calcification with 2% (wt/vol) Alizarin Red S (Sigma), vas-
cular invasion using Masson’s trichrome (Merck), or bone formation with
1% (wt/vol) methylene blue (Sigma) and basic fuchsin (Sigma) according to
standard procedures. Histological sections were analyzed using a light mi-
croscope (E600; Nikon).
Quantitative Glycosaminoglycan and DNA Assay. MSC micromasses were an-
alyzed for glycosaminoglycan content as previously described (31). All values
were normalized to their respective DNA amount and expressed as the gly-
cosaminoglycan/DNA (μg/μg) ratio.
Quantification of GREM1, FRZB, and DKK1 Protein Levels in Conditioned Media.
After 32 d of chondrogenic differentiation, medium was conditioned for 3 d.
Protein levels of GREM1 (USCN Life Science), FRZB (R&D Systems), and DKK1
(R&D Systems) secreted by the cells into the culture supernatant were mea-
sured by ELISA following the instructions of each manufacturer.
Statistical Analysis. Statistical differences between two groups were analyzed
using the Student t test or one-way ANOVA. Statistical significance was set
to P < 0.05 and was indicated with an asterisk or hash (#) sign. Results are
presented as mean ± SD.
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